SCHEMBL5833583

SCHEMBL5833583

CC(C)c1c(C(N)=O)ccc(N(c2cc(F)ccc2C(N)=O)C2CCN(Cc3nccs3)CC2)c1C(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 6/20 0.39
CYP2C9 P11712 4/20 0.39
TSHR P16473 2/20 0.39
CYP1A2 P05177 2/20 0.39
CYP2C19 P33261 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
SCN8A Q9UQD0 2/20 0.35
NAMPT P43490 1/20 0.35
TLR9 Q9NR96 2/20 0.35
TLR8 Q9NR97 2/20 0.35
TLR7 Q9NYK1 2/20 0.35
CYP2D6 P10635 3/20 0.34
KCNH2 Q12809 1/20 0.34
GPR119 Q8TDV5 1/20 0.34
USP2 O75604 2/20 0.34
CACNA2D1 P54289 1/20 0.34
OPRD1 P41143 2/20 0.34
OPRM1 P35372 1/20 0.34
SCN1A P35498 1/20 0.33
MCHR1 Q99705 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5829831 0.88 CYP3A4 (0.37) CYP3A4CYP2C9TSHRCYP1A2CYP2C19
SCHEMBL5833576 0.83 OPRD1 (0.46) CYP3A4CYP2C9TSHRCYP1A2CYP2C19
SCHEMBL5829605 0.74 PARP1 (0.43) SMN1; SMN2SCN8AKCNH2OPRD1OPRM1
SCHEMBL5829900 0.74 PARP1 (0.46) SMN1; SMN2OPRD1OPRM1
SCHEMBL5828656 0.74 OPRM1 (0.41) TLR9TLR8TLR7KCNH2OPRD1
SCHEMBL5829647 0.74 PARP1 (0.42) CYP2C19SMN1; SMN2TLR9TLR8TLR7
SCHEMBL5829874 0.73 PARP1 (0.47) CYP1A2CYP2C19SMN1; SMN2TLR9TLR8
SCHEMBL5829864 0.73 PARP1 (0.44) CYP3A4TSHRKCNH2OPRD1OPRM1
SCHEMBL5829616 0.73 PARP1 (0.40) OPRD1OPRM1
SCHEMBL5630843 0.72 OPRD1 (0.52) OPRD1OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7008952-B2 4-(phenyl-(piperidin-4yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders ASTRAZENECA AB (SE) 2006-03-07 US claimed